1067 Companies
French clinical-stage biotech firm Cellectis S.A. is developing immuno-oncology treatments using gene-edited T-cells that express chimeric antigen receptors. The company is working on multiple prod...
Cellectis S.A. Annual Report 2021France-based biopharmaceutical firm Genfit S.A. has made significant strides in the development of drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's f...
GENFIT S.A. Annual Report 2023Choice Properties Real Estate Investment Trust is a prominent real estate investment company in Canada that specializes in owning, managing, and developing commercial properties like retail centers...
Choice Properties REIT Annual Report 2023Scientific instruments developer Bruker Corporation and its subsidiaries have made waves in the international market with their cutting-edge analytical and diagnostic solutions. Bruker operates thr...
Bruker Annual Report 2023Healthcare software and payment platform provider Phreesia, Inc. is rapidly gaining popularity in the United States and Canada due to its innovative SaaS-based technology. The Phreesia Platform off...
Phreesia Annual Report 2023Sydney-based biopharmaceutical firm, Kazia Therapeutics Limited, has been making strides in the development of anti-cancer drugs. Its leading development candidate, Paxalisib, is a brain-penetrant ...
Kazia Therapeutics Limited Annual Report 2023Avenue Therapeutics, a New York-based specialty pharmaceutical firm, is currently focused on developing and bringing revolutionary products to market for use in the acute/intensive care hospital se...
Avenue Therapeutics, Inc. Annual Report 2023With a focus on serving the needs of expectant and new mothers, Destination Maternity Corporation is a leading retailer of maternity clothing. The company's product offerings include a wide range o...
Destination Maternity Corporation Annual Report 2023Flaherty & Crumrine Incorporated, a renowned investment management firm, has launched and is currently managing a closed-ended balanced mutual fund named Flaherty & Crumrine Preferred Securities In...
Farmaforce Annual Report 2020Myovant Sciences is a healthcare company dedicated to revolutionizing women's and men's healthcare with its lead product candidate, relugolix. This once-daily, oral GnRH receptor antagonist has had...
Myovant Sciences Ltd. Annual Report 2021AbbVie Inc., a pharmaceutical company based in North Chicago, Illinois, has made significant strides in the industry by discovering, developing, manufacturing, and selling various drugs worldwide. ...
AbbVie Annual Report 2023NantKwest is a clinical-stage immunotherapy company that is focused on utilizing the innate immune system to treat cancer and infectious diseases. The company is a leading producer of clinical dose...
NantKwest, Inc. Annual Report 2018Intercept Pharmaceuticals Targets Commercialization of Breakthrough Therapeutics for Non-Viral Liver Diseases Intercept Pharmaceuticals, Inc., a leading US biopharmaceutical company, is focused on...
Intercept Pharmaceuticals Annual Report 2021Karyopharm Therapeutics Inc., a pharmaceutical company focused on developing drugs that fight nuclear export in cancer and other diseases, is making strides in the medical community. The company ha...
Karyopharm Therapeutics Annual Report 2023Dynavax Technologies Corporation, a US-based commercial stage biopharmaceutical company, is primarily engaged in developing and commercializing vaccines. Among its product lineup is HEPLISAV-B, an ...
Dynavax Annual Report 2023